Compare Vanguard Intermediate Term Corporate Bond ETF (VCIT) vs Health Care Select Sector SPDR Fund (XLV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Vanguard Intermediate Term Corporate Bond ETF vs Health Care Select Sector SPDR Fund — how do they compare? Vanguard Intermediate Term Corporate Bond ETF trades at $80.48, while Health Care Select Sector SPDR Fund trades at $167.05. The key difference: Health Care Select Sector SPDR Fund is trading nearer its 52-week high, Vanguard Intermediate Term Corporate Bond ETF nearer its low. Which is the better fit depends on your goals.
| VCIT | XLV | |
|---|---|---|
Sector | Fixed Income | — |
52-Week High | $84.82 | $175.68 |
52-Week Low | $80.31 | $134.13 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
VCIT trades at $80.46, down 0.09% on the day, with a bearish technical signal from moving averages but bullish oscillators. The ETF offers a 4.8% yield and low 0.03% expense ratio, attracting institutional interest as seen with HB Wealth Management increasing holdings by 242.9% in Q3 2026 (SEC filing, September 2026). Recent news highlights its competitive edge in intermediate-term corporate bonds.
The outlook remains favorable for income investors seeking yield with moderate risk, though bearish momentum and interest rate sensitivity pose near-term headwinds. Key opportunities include cost efficiency and diversification, while risks involve market volatility and economic shifts affecting corporate credit.
XLV trades at $167.16, down 2.5% amid testing key support levels, with technical indicators showing mixed signals between bullish moving averages and bearish oscillators. The healthcare ETF maintains defensive appeal with upcoming dividend payments and sector rotation benefits during potential Fed tightening. Recent options activity shows increased put volume, suggesting some near-term caution among traders.
Healthcare sector strength and defensive positioning support XLV's long-term outlook, though near-term technical weakness and sector-specific headwinds from failed drug trials present risks. The ETF's low expense ratio and diversified healthcare exposure provide stability, with earnings momentum and FDA approvals driving fundamental strength.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Vanguard Intermediate Term Corporate Bond ETF
VCIT tracks the Bloomberg U.S. 5-10 Year Corporate Bond Index, providing exposure to investment-grade debt from industrial, utility, and financial companies. It acts as a middle-ground bond fund, offering higher yields than short-term bonds with less price volatility than long-term corporate debt.
Read more on VCIT →About Health Care Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →
